​

TherapeuticsMD (TXMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

TXMD Stock Rating

TherapeuticsMD stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (50.00%), 3 Hold (37.50%), 1 Sell (12.50%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 3 4 Strong Sell Sell Hold Buy Strong Buy

TXMD Price Target Upside V Benchmarks

TypeNameUpside
StockTherapeuticsMD-
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks18.82%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.25$1.25$1.25
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24351--9
Oct, 24351--9
Sep, 24351--9
Aug, 24351--9
Jul, 24251--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 15, 2022Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

$-40 $-31 $-22 $-13 $-4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-38.58$-25.83$-10.35$-0.55$-0.19---
Avg Forecast$-30.80$-20.17$3.01$-0.75$0.15$0.16$0.17$0.19
High Forecast$-30.80$-20.17$3.01$-0.75$0.15$0.16$0.17$0.19
Low Forecast$-30.80$-20.17$3.01$-0.75$0.15$0.16$0.17$0.19
Surprise %25.26%28.06%-443.85%-26.67%-226.67%---

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$64.87M$86.95M$69.96M$1.30M----
Avg Forecast$63.06M$97.28M$69.77M$2.00M$9.00M$9.20M$9.30M$9.50M
High Forecast$63.06M$97.28M$69.77M$2.42M$9.00M$9.20M$9.30M$9.50M
Low Forecast$63.06M$97.28M$69.77M$1.58M$9.00M$9.20M$9.30M$9.50M
Surprise %2.87%-10.62%0.27%-34.90%----

Net Income Forecast

$-350M $-250M $-150M $-50M $50M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-212.70M$-205.60M$112.00M$-10.28M$-2.18M---
Avg Forecast$-321.58M$-190.53M$31.38M$-230.54M$1.57M$1.67M$1.77M$1.98M
High Forecast$-321.58M$-152.42M$31.38M$-184.43M$1.57M$1.67M$1.77M$1.98M
Low Forecast$-321.58M$-228.64M$31.38M$-276.65M$1.57M$1.67M$1.77M$1.98M
Surprise %-33.86%7.91%256.88%-95.54%-239.26%---

TXMD Forecast FAQ

Is TherapeuticsMD stock a buy?

TherapeuticsMD stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that TherapeuticsMD is a favorable investment for most analysts.

What is TherapeuticsMD's price target?

TherapeuticsMD's price target, set by 8 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.25.

How does TherapeuticsMD stock forecast compare to its benchmarks?

TherapeuticsMD's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (18.82%).

What is the breakdown of analyst ratings for TherapeuticsMD over the past three months?

  • November 2024: 33.33% Strong Buy, 55.56% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 33.33% Strong Buy, 55.56% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 33.33% Strong Buy, 55.56% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.

What is TherapeuticsMD’s EPS forecast?

TherapeuticsMD's average annual EPS forecast for its fiscal year ending in December 2025 is $0.16, marking a -184.21% decrease from the reported $-0.19 in 2024. Estimates for the following years are $0.17 in 2026, and $0.19 in 2027.

What is TherapeuticsMD’s revenue forecast?

TherapeuticsMD's average annual revenue forecast for its fiscal year ending in December 2025 is $9.2M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $9.3M, and $9.5M for 2027.

What is TherapeuticsMD’s net income forecast?

TherapeuticsMD's net income forecast for the fiscal year ending in December 2025 stands at $1.67M, representing a -176.60% decrease from the reported $-2.181M in 2024. Projections indicate $1.77M in 2026, and $1.98M in 2027.